Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Liraglutide was first approved for the treatment of type 2 diabetes by the FDA in 2010 and was later approved for chronic weight management in 2014
powder) or vegan/vegetarian preferences
The "direct-to-employer" access model allows employers to work directly with a vendor to provide GLP-1 medications to eligible employees, bypassing PBMs, allowing for more pricing transparency and control
Fear of needles, inconvenience, and social stigma all play a role
nbc4i.co/3LqYjfC The Trump administration on Thursday announced its newest pharmaceutical agreement under its Most Favored Nation (MFN) policy, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 products at discounted prices
Ecnoglutide A long-acting GLP-1 receptor agonist designed for twice-monthly or potentially monthly dosing
US$ 27.37
US$ 24.47
US$ 22.28
US$ 28.30
US$ 24.45
US$ 29.01
US$ 28.10
US$ 25.89
US$ 28.01
US$ 26.90
US$ 28.62
